Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings ...

The series of spin rides is a fundraiser for Memorial Sloane Cancer Center, which specializes in the treatment and diagnosis ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

HealthDay News — The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, ...

I watched my doctor, wondering how he was going to break the news to me – news that would change my life and shake the world ...

The data she presented also shows that the survival rate for cervical, breast, prostate, and thyroid cancer in Korea ranges ...